Prospective Real-World Evidence Study of the IpsiHand® System in Adult Stroke Survivors
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-85
SponsorNeurolutions, Inc.
About this trial
This study focuses on monitoring real-world customers who have been prescribed the IpsiHand® as part of their rehabilitation post-stroke. This study aims to evaluate their progress over time, assessing motor recovery, functional independence in activities of daily living (ADLs), caregiver burden, and health economic outcomes.
Eligibility criteria
Qualifiers
Adult age 18-85 years.
Diagnosis of stroke six or more months prior with upper extremity weakness.
Has received an IpsiHand® system as a commercial customer for stroke rehabilitation.
Disqualifiers
Severe cognitive impairment that would impede utilization of IpsiHand®
Any contraindications to IpsiHand® device use
Inability to comprehend English
Trial design
Treatments tested in this trial
- IpsiHand
Treatment groups
100 Participants
are divided into 1 treatment groupLocations
This trial has no locations
Sponsors and collaborators
Neurolutions, Inc.
Lead sponsor
Source ClinicalTrials.gov